AKP Phnom Penh, January 08, 2026 —

Malaysian Ministry of Science, Technology and Innovation (MOSTI) said on January 7 that bio-economy is expected to expand in value in the coming years and play a larger role in gross domestic product (GDP) growth.

MOSTI Minister Chang Lih Kang said the Bioeconomy Corporation, the ministry’s lead development agency for Malaysia’s biotechnology industry, will drive this growth and steer the country’s bioeconomy toward greater global competitiveness. He expressed confidence in its five-year plan focused on six high-value, high-growth sub-sectors, including next-generation proteins, regenerative propagation, sustainable materials, bio-based chemicals, regenerative medicine and precision diagnostics.

CEO of Bioeconomy Corporation Mohd Khairul Fidzal Abdul Razak highlighted a target of at least 2.2 billion MYR (550 million USD) in 2026 revenue from companies under its BioNexus Status and Bio-based Accelerator (BBA) programmes. These are central to Malaysia’s strategy to become an advanced biotechnology nation by 2030.

Last year, Malaysian companies supported by the Bioeconomy Corporation recorded a 60% increase in investment and commercial value, rising from 1.55 billion MYR in 2024 to more than 2.44 billion MYR.

AKP-VNA